Browsing Tag
Antibody Drug Conjugates
4 posts
TuHURA Biosciences extends runway into 2028 as HURA investors wait for Merkel cell carcinoma data
TuHURA has bought time with a $50m facility. The harder test is whether IFx-2.0 can deliver before HURA investors lose patience.
Why TROP2 ADC competition may hinge on payload differentiation after AKTX-101 data
Find out how AKTX-101 could reshape TROP2 ADC competition and what it means for oncology investors and strategy.
Avacta Group (AIM: AVCT) claims preCISION payload delivery shows structural advantages over ADCs as AVA6103 nears clinic
Avacta Group plc releases new data claiming preCISION delivery advantages over ADCs as AVA6103 prepares to enter clinical trials. Read more.
Suven Pharmaceuticals reports 12% revenue growth for Q2 with strong outlook
Suven Pharmaceuticals Ltd. (BSE: 530239, NSE: SUVENPHARM), a technology-focused Contract Development and Manufacturing Organization (CDMO) headquartered in Hyderabad,…